# Colgate Oral Pharmaceuticals, Inc., Dallas, TX – FDA Inspections

Source: https://www.keypedia.com/companies/colgate-oral-pharmaceuticals-inc/a9f93a33-c74c-4686-9817-4ddfae84d6e4

> Inspection records and compliance data for Colgate Oral Pharmaceuticals, Inc. in Dallas, Texas. 5 FDA inspections on record (1 OAI), 1 warning letter, last inspected November 18, 2015.

---

## Details

- Name: Colgate Oral Pharmaceuticals, Inc.
- FEI Number: 1000117969
- Business Operations: FDF MANUFACTURE
- Address Line 1: 14335 Gillis Rd
- City: Dallas
- State: Texas
- Zip Code: 75244
- Country Name: United States
- Address: 14335 Gillis Rd, Dallas, Texas 75244, United States
- Country: United States

## Related Documents

- FDA Inspection 953510 - Colgate Oral Pharmaceuticals, Inc. - 2015-11-18 — classification: No Action Indicated (NAI), source: FDA, date: November 18, 2015
- [WARNING_LETTER - Colgate Oral Pharmaceuticals, Inc. - 2014-08-21](https://www.keypedia.com/records/warning_letter/colgate-oral-pharmaceuticals-inc/3ff1449e-7be6-41b9-9f27-429779f5337b) — source: FDA, date: August 21, 2014
- FDA Inspection 846902 - Colgate Oral Pharmaceuticals, Inc. - 2013-08-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 23, 2013
- FDA Inspection 771703 - Colgate Oral Pharmaceuticals, Inc. - 2012-03-09 — classification: No Action Indicated (NAI), source: FDA, date: March 9, 2012
- FDA Inspection 771703 - Colgate Oral Pharmaceuticals, Inc. - 2012-03-09 — classification: Official Action Indicated (OAI), source: FDA, date: March 9, 2012
- [FDA Inspection 771703 - Colgate Oral Pharmaceuticals, Inc. - 2012-03-09](https://www.keypedia.com/records/fda_inspections/colgate-oral-pharmaceuticals-inc/aad318da-0177-47c9-8ae7-29d66dc80fde) — classification: Official Action Indicated (OAI), source: FDA, date: March 9, 2012
- [FDA Inspection 695934 - Colgate Oral Pharmaceuticals, Inc. - 2010-11-01](https://www.keypedia.com/records/fda_inspections/colgate-oral-pharmaceuticals-inc/ca17774d-de7c-4490-b00a-15c7ff2a1d7c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2010
- FDA Inspection 586568 - Colgate Oral Pharmaceuticals, Inc. - 2009-05-01 — classification: No Action Indicated (NAI), source: FDA, date: May 1, 2009

## Related Companies

- [Health Specialty](https://www.keypedia.com/companies/health-specialty/2d5652d1-483f-452d-a41b-5501e4ac9046)
- [PPD, Inc., part of Thermo Fisher Scientific](https://www.keypedia.com/companies/ppd-inc-part-of-thermo-fisher-scientific/6e887c67-c334-42e7-80d9-cfa8be392b57)
- [Innovation Specialties, Inc.](https://www.keypedia.com/companies/innovation-specialties-inc/4171e297-7e30-4094-bf04-b64edbd54848)
- [Joel Schlessinger, M.D.](https://www.keypedia.com/companies/joel-schlessinger-md/43825d93-b0cc-4998-a844-76df360610ee)
- [Bausch & Lomb Incorporated](https://www.keypedia.com/companies/bausch-lomb-incorporated/961e1d16-e42e-477e-a270-c3473a10fad3)
- [Baystate Medical Center IRB](https://www.keypedia.com/companies/baystate-medical-center-irb/616470e2-9491-4cf7-850b-0c45ef7772af)
- [Purdue Pharma L.P.](https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346)
- [Neos Therapeutics, LP](https://www.keypedia.com/companies/neos-therapeutics-lp/b0c09540-d002-4817-8f57-7903d10d044f)
- [Merck & Co. Inc](https://www.keypedia.com/companies/merck-co-inc/a46a094a-b27d-49bf-bde5-42441f92c622)
- [Impax Laboratories, LLC.](https://www.keypedia.com/companies/impax-laboratories-llc/7d8ef88a-fa0d-491d-b7f5-600a09806c0d)

## Related Officers

- [Michael M. Levy](https://www.keypedia.com/people/michael-m-levy/3e0fdd21-e691-406d-81cf-4fe2460a6309)
